Two groups of scientists managed to isolate antibodies capable of neutralizing the coronavirus SARS-CoV-2 in laboratory conditions. On the eve of May 4, a group of scientists from the Netherlands reported about a successful laboratory experiment; their article was published in the journal Nature. On May 5, scientists created antibodies to coronavirus in the scientific laboratory of the Israel Institute for Biological Research (IIBR). Israel’s Minister of Defence Naftali Bennett announced this at a press conference.
In both cases, scientists managed to create the allocation of monoclonal antibodies that attack the virus and destroy its spiky protein, through which the virus penetrates into human cells. The obtained antibodies will neutralize SARS-CoV-2 and will prevent it from spreading. Both groups of scientists call the results of tests a breakthrough, as in theory, these antibodies can independently cope with the pandemic COVID-19 and will help to prevent epidemics of coronavirus infections in the future. The scientists tell, however, that they will have to do animal testing and human clinical trials to confirm the effectiveness of the obtained antibodies.
In April, the World Health Organization published a list of 83 prospective vaccine developments against COVID-19.